1. Complement Protein Levels Decrease with Tumour Severity in Pancreatic Ductal Adenocarcinoma. (2022) Authors: Nsingwane, Z.; Elebo, N.; Mhlambi, N.; Devar, J.; Omoshoro-jones, J.; Smith, M.; Candy, G.; Nweke, E.E. Journal: HPB Issue: Volume 24(2022)Supplement 1 Page Start: S266 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Metabolic profiling of a cohort of pancreatic ductal adenocarcinoma (PDAC) patients of african ancestry. (2021) Authors: ELebo, N.; Cacciatore, S.; Fru, P.; Omoshoro-Jones, J.; Zerbini, L.; Devar, J.; Smith, M.; Candy, G.; Nweke, E.E. Journal: HPB Issue: Volume 23(2021)Supplement 3 Page Start: S813 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Metabolites Levels Correlate to Tumour Stage and Survival in Pancreatic Ductal Adenocarcinoma Patients. (2022) Authors: Elebo, N.; Omoshoro-Jones, J.; Fru, P.; De Wet van Zyl, C.; Vorster, C.; Smith, M.; Cacciatore, S.; Candy, G.; Nweke, E.E. Journal: HPB Issue: Volume 24(2022)Supplement 1 Page Start: S309 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Proteogenomic analysis demonstrates novel potential targets of pancreatic ductal adenocarcinoma in African patients. (2021) Authors: Nweke, E.E.; Naicker, P.; Aaron, S.; Stoychev, S.; Devar, J.; Tabb, D.; Omoshoro-Jones, J.; Smith, M.; Candy, G. Journal: HPB Issue: Volume 23(2021)Supplement 1 Page Start: S229 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Proteome Analysis Distinguishes Gallbladder Cancer from Gallstone Disease in Patients of African Ancestry. (2022) Authors: Baichan, P.; Naicker, P.; Devar, J.; Smith, M.; Candy, G.; Nweke, E.E. Journal: HPB Issue: Volume 24(2022)Supplement 1 Page Start: S28 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Quantitative proteonomics confirms microRNA targets in pancreas cancer to explain why cetuximab has limited efficacy in prolonging patient survival. (2019) Authors: Brand, M.; Nweke, E.E.; Zhou, L.; He, C.; Majole, M.; Candy, G. Journal: HPB Issue: Volume 21(2019)Supplement 3 Page Start: S999 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. SPP-1 is Overexpressed in Resected Pancreatic Ductal Adenocarcinoma (PDAC) Tumours. (2022) Authors: Mhlambi, N.H.M.; Nsingwane, Z.; Candy, G.; Devar, J.; Omoshoro-Jones, J.; Smith, M.; Nweke, E.E. Journal: HPB Issue: Volume 24(2022)Supplement 1 Page Start: S260 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗